{"brief_title": "Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation", "brief_summary": "Treatment of smokers with a tricyclic antidepressant, nortriptyline, can reduce tobacco withdrawal symptoms and increases long term cessation rates when combined with transdermal nicotine and a behavioral cessation programs. The study is a placebo-controlled, randomized, parallel group trial in which smokers aged 18-70 will be subject to the combination of oral and patch treatments.", "condition": "Smoking", "intervention_type": "Drug", "intervention_name": "transdermal nicotine", "description": "Transdermal nicotine 21 mg, titrated down plus placebo", "arm_group_label": "2", "criteria": "Inclusion Criteria: - Aged 18-70, - smoking > 10 cigarettes per day, - no current major depression, - no concurrent psychiatric medications Exclusion Criteria:", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00018148.xml"}